Our employees - Securing a successful future
Actelion’s business momentum is mirrored in the growing number of its employees. Our staff represent the best professional attributes, blending biotech innovation with pharmaceutical discipline and the highest ethical standards.
As part of our strategy, we continue to place a high priority on attracting, developing and retaining highly talented people. Employees who identify with the goals and values of our company have transformed the vision of Actelion’s founders into reality: People with passion and expertise are paving the way to our future success.
Actelion – Together we innovate
Actelion’s four Strategic Principles describe the fundamental priorities required to reach its long-term business objective – to become one of the top biopharmaceutical companies in the world:
1. Follow innovation where it leads
Pursue top quality science, internally and externally, balanced with medical need and commercial potential.
2. Retain the value of innovation
Develop projects ourselves and seek partners when necessary to maximize value. Control destiny and retain independence.
3. Excel in sales and marketing
Expand innovative commercial capabilities to new customers and regions. Manage alliances, putting the product first.
4. Drive core values together
Culture of Innovation, Trust & Teamwork, Open Communication, and Results Driven.
The key components of Actelion's strategy are:
1. Build our existing businesses in PAH and lipid storage disorders while developing or licensing additional synergetic products.
2. Pursue an R&D-focused growth strategy by pursuing internal projects, especially those which would accelerate value creation. Selectively form partnerships for these products to minimize risk, and optimize investment and return.
3. Seek licensing deals or acquisitions that are synergetic to existing businesses or to provide an infrastructure platform for pipeline products.
4. Focus on people: It takes professionals from many areas of expertise, working together over a sustained period of time, to create an innovative medicine. We know that products don’t discover or sell themselves and so continue to grow our innovative team of creative minds.
